<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-131344</identifier>
<setSpec>1130-6343</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Proarrhythmic effects of domperidone in infants: a systematic review</dc:title>
<dc:description xml:lang="en">Aims: To assess the association of the use of domperidone in infants with QTc interval prolongation and proarrhythmic events. Methods: A systematic search of the scientific literature was conducted without any date or language restriction. The electronic database MEDLINE and the sources LILACS, ScIELO and Cochrane library were consulted. Results: From the twelve identified studies, eight were excluded because they did not meet the inclusion criteria. One case report and three pilot studies were selected. Rocha et al (2005) reported the case of an infant (age 3 months) with QTc interval = 463ms after being treated during one month with 1.8 mg/kg/day of oral domperidone. Djeddi et al (2008) administered an average dose of 1.3 mg/kg/day to 31 neonates; QTc interval (..) (AU)</dc:description>
<dc:creator>Marzi, Marta</dc:creator>
<dc:creator>Weitz, Dario</dc:creator>
<dc:creator>Caraballo, Lucia</dc:creator>
<dc:creator>Molina, Gabriel</dc:creator>
<dc:creator>Piskulic, Laura</dc:creator>
<dc:creator>Avila, Aylen</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Determinar si existe evidencia de prolongación del intervalo QTc y efectos proarrítmicos asociados al uso de domperidonaoral en infantes. Método: Se realizó una revisión sistemática de la literatura científica consultando la base de datos electrónica MEDLINEy las fuentes LILACS, ScIELO y Biblioteca Cochrane a través de la Biblioteca Virtual de Salud, sin límite de fecha ni de idioma. Resultados: De los estudios identificados se excluyeron ocho por no cumplir con los criterios de inclusión, quedando seleccionados un reporte de caso y tres estudios pilotos. Rocha etal (2005) reportan el caso de un niño de 3 meses con intervalo QTc=463 mseg tras un mes de tratamiento con 1,8 mg/kg/díade domperidona oral. Djeddi et al (2008) administraron unadosis promedio de 1,3 mg/kg/día a 31 neonatos, observando prolongación del intervalo (..) (AU)</dc:description>
<dc:source>Farm Hosp;38(5): 438-444, sept.-oct. 2014. ilus, tab</dc:source>
<dc:identifier>ibc-131344</dc:identifier>
<dc:title xml:lang="es">Revisión Sistemática de la evidencia de efectos proarrítmicos de domperidona en infantes</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d1150^s22036</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4354^s22020</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d53366</dc:subject>
<dc:subject>^d19558^s22036</dc:subject>
<dc:type>article</dc:type>
<dc:date>201410</dc:date>
</metadata>
</record>
</ibecs-document>
